TransDigm Group Incorporated (TDG) FY2025 Annual Statement of Cash Flows
2024-10-01 to 2025-09-30
Statement of Cash Flows
2024-10-01 to 2025-09-30
Swipe to see the full flow
Chart details
TransDigm Group Incorporated cash flow reconciliation, Oct 1, 2024 through Sep 30, 2025
Cash flows for Oct 1, 2024 through Sep 30, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Sep 30, 2024. Ending cash: Sep 30, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Sep 30, 2024
- 6,261,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 2,038,000,000 US dollars. Net cash provided.
- Gain on sale of businesses, net
- negative 10,000,000 US dollars
- Amortization of intangible assets and product certification costs
- 204,000,000 US dollars
- Deferred income taxes
- negative 10,000,000 US dollars
- Non-cash stock and deferred compensation expense
- 157,000,000 US dollars
- Accounts payable
- 38,000,000 US dollars
- Amortization of inventory step-up
- 10,000,000 US dollars
- Foreign currency exchange losses
- 10,000,000 US dollars
- Amortization of loss contract reserves
- negative 51,000,000 US dollars
- Accrued and other liabilities
- negative 102,000,000 US dollars
- Net income
- 2,074,000,000 US dollars
- Inventories
- negative 156,000,000 US dollars
- Accrued interest
- 23,000,000 US dollars
- Refinancing costs
- 11,000,000 US dollars
- Trade accounts receivable
- negative 212,000,000 US dollars
- Income taxes (receivable) payable
- negative 94,000,000 US dollars
- Depreciation
- 163,000,000 US dollars
- Other assets
- negative 55,000,000 US dollars
- Amortization of debt issuance costs, original issue discount and premium
- 38,000,000 US dollars
- Gain on settlement of the Esterline Retirement Plan (the “ERP”)
- 0 US dollars
- Cash refund for the ERP settlement, net
- 0 US dollars
- Investing activities
- negative 595,000,000 US dollars. Net cash used.
- Capital expenditures
- negative 222,000,000 US dollars
- Other investing transactions, net
- 46,000,000 US dollars
- Acquisition of businesses, net of cash acquired
- negative 419,000,000 US dollars
- Financing activities
- negative 4,900,000,000 US dollars. Net cash used.
- Dividends and dividend equivalent payments
- negative 9,629,000,000 US dollars
- Financing costs and other, net
- negative 10,000,000 US dollars
- Proceeds from issuance of senior secured notes, net
- 494,000,000 US dollars
- Proceeds from term loans, net
- 6,015,000,000 US dollars
- Proceeds from trade receivable securitization facility, net
- 238,000,000 US dollars
- Repayments of senior subordinated notes, net
- negative 2,650,000,000 US dollars
- Repurchases of common stock
- negative 500,000,000 US dollars
- Repayment on term loans
- negative 3,622,000,000 US dollars
- Repayments of senior secured notes
- 0 US dollars
- Proceeds from exercise of stock options
- 166,000,000 US dollars
- Proceeds from issuance of senior subordinated notes, net
- 4,598,000,000 US dollars
- Operating adjustment reconciliation
- 690,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 16,411,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 641,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 4,000,000 US dollars
- Ending cash on Sep 30, 2025
- 2,808,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 8,303,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 3,453,000,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- 0.98×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- Operating cash flow
- 2,038,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 222,000,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 1,816,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income exceeds operating cash. The diagram allocates $2.04B of net income directly to operating cash and $36.00M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 2,038,000,000 US dollars minus 222,000,000 US dollars equals 1,816,000,000 US dollars.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
